Consistent with that notion, blood NK cells expresse more FCGR3A mRNA, the gene that encodes CD16a, than tumor-infiltrating NK cells in bladder cancer and that was driven by transforming growth factor receptor β47. The gene discussed is FCGR3A; the disease is neoplasm.